ONCE News and Press, Spark Therapeutics Inc. From 12/17/19

As one of the largest pharma companies out there, I suppose it stands to reason that Roche ( OTCQX:RHHBY ) would have an above-average level of newsflow, but tracking the developments at Roche over the last couple of months has been like trying to sip from a firehose. It’s well worth ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . The crisis at Boeing is deepening after the planemaker halted production of a 737 line for the first time in two decades, as the ...

Merger activity decreased with four new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $300 million or $4.00 per share in cash. The acquisition of Synthorx (THOR) by Sanofi (SNY) for $2.35 billio...

The FTC closes its probe into Roche's ( OTCQX:RHHBY ) $4.8B acquisition of Spark Therapeutics (NASDAQ: ONCE ). More news on: Roche Holding AG, Spark Therapeutics, Inc., Healthcare stocks news, Top stock market news Read more ...

After big biopharma Astellas   (OTC: ALPMY) (OTC: ALPMF) agreed to acquire clinical-stage gene therapy company Audentes Therapeutics (NASDAQ: BOLD) for $3 billion in cash, uniQure 's (NASDAQ: QURE) shares have jumped 13% at 12:15 pm EDT on Tuesday. Although Audentes and uni...

Introduction I have covered companies developing immunotherapy treatments, with a focus on T cell therapies. While I have no doubt T cell therapies will be the next pillar in cancer treatments, current generation of therapies are plagued with various limitations. For example, approved CA...

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 11/14/2019. Please visit our Tracking John Paulson’s Paulson & Co...

Merger activity decreased, with three new deals announced and five deals closing. Deal Statistics: New Deals: The acquisition of Carolina Financial Corporation (CARO) by United Bankshares (UBSI) for $1.1 billion in an all-stock deal. Under the terms of the agreement, United will...

This article is part of a series that provides an ongoing analysis of the changes made to Prem Watsa's 13F portfolio on a quarterly basis. It is based on Watsa's regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Prem Watsa's Fairfax Financial Holdings Portfolio series to g...

Four times a year, I spend several hours combing through Form 13F filings from the hedge funds that specialize in M&A. I document and analyze which merger stocks the funds have bought and which ones they haven't. I then compile the top 10 stocks held in these funds and share it with everyo...